TRVI (Trevi Corp) Bozor qiymatining balans qiymatiga nisbati
Trevi Therapeutics (TRVI) qichishish va nevrologik patologiyalar uchun davolash portfelini kengaytirish orqali tartibga soluvchi xavflarni minimallashtirmoqda. Kompaniya hozirda bozorga ta'sir ko'rsatish imkoniyatiga ega emas va tashqi investitsiyalarga tayanadi, biroq kelajakdagi patentlar unga terapiya uchun yuqori narxlarni belgilash imkonini beradi. Kompaniya narxlarining 5.93 darajasidagi evolyutsiyasi aktivning dinamikasini ko'rsatadi. Biznesning barqarorligi yo'taldan kurashish uchun innovatsiyalarni ishlab chiqayotgan AQShga asoslangan R&D markazi tomonidan qo'llab-quvvatlanadi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_TRVI_-_Trevi-Therapeutics_-_Capitalization-to-Book-Value-Ratio "TRVI Trevi Therapeutics, Inc. Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Trevi Therapeutics Inc (TRVI) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Trevi Therapeutics|TRVI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Trevi Pharma|TRVI - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Trevi Pharma|TRVI - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzi Trevi Therapeutics
Kompaniyaning asosiy tahlili:TRVI - Trevi Therapeutics
Investorlar Trevi Therapeutics (TRVI) kompaniyasining salohiyatini qichishish va yo'tolni davolash vositalarini tijoratlashtirishdan kelajakda tushadigan daromadlar prizmasi orqali bahlamoqdalar. Ushbu ko'rsatkich aksiyalarning bozor qiymatini sof aktivlar bilan solishtirib, biznesning haqiqiy kapitaliga nisbatan haddan tashqari yuqori baholanganlik darajasini aniqlaydi. Kompaniyani bozor qiymatining balans aktivlariga nisbatini tahlil qilish orqali bozorning asossiz optimizmini yoki narxlarning keskin korreksiyasi bilan bog'liq yashirin xatarlarni aniqlash mumkin.
Toʻgʻridan-toʻgʻri raqobatchilar
Biogen Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|NBIX (neurocrine.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp|Amylyx Pharmaceuticals (AMLX) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori PRAX|Anavex Life Sciences Corp. (AVXL) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CeriBell Inc (CBLL)|PRTA: Bozor kapitallashuvining balans qiymatiga nisbati|ALEC - Bozor qiymatining balans qiymatiga koeffitsiyenti|ANNX - Kapitallashuvning sof aktivlarga nisbati|OMER - Bozor qiymatining balans qiymatiga nisbati|Neurogene - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi AC Immune S.A.|VYGR - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Neumora Corp (NMRA)|Kapitallashuvning sof aktivlarga nisbati Scilex Holding Company|Bozor kapitallashuvining balans qiymatiga multiplikatori tevogen.com (TVGN)|Bozor kapitallashuvining balans qiymatiga nisbati Alpha Cognition Inc.|Balans qiymatiga nisbatan bozor qiymati cogrx.com CGTX|IKT (Inhibikase) - Bozor kapitallashuvining balans qiymatiga nisbati|SAVA: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati assertiotx.com ASRT|Coya Therapeutics (COYA) - Balans qiymatiga nisbatan bozor qiymati|VTGN (VistaGen Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati OVID|ABOS - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi CervoMed Corporation (CRVO)|ATHE: Bozor kapitallashuvining balans qiymatiga nisbati|CLNN - Bozor qiymatining balans qiymatiga koeffitsiyenti|PepGen Corp - Kapitallashuvning sof aktivlarga nisbati|jupiterneurosciences.com (JUNS) - Bozor kapitallashuvining balans qiymatiga nisbati|RLMD - Kapitallashuvning sof aktivlarga nisbati|Annovis Bio Corporation (ANVS) - Bozor kapitallashuvining balans qiymatiga multiplikatori|GRCE: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi fireflyneuro.com|Bozor kapitallashuvining balans qiymatiga nisbati KLTO (Klotho Neurosciences Inc)|Kapitallashuvning sof aktivlarga nisbati NRSN (neurosense-tx.com)|Bozor qiymatining balans qiymatiga nisbati RVPH|MTVA - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati NeurAxis, Inc. NRXS|HSDT: Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati passagebio.com PASG|Balans qiymatiga nisbatan bozor qiymati Neuphoria Therapeutics|Kapitallashuvning sof aktivlarga nisbati Minerva Neurosciences Corp|Bozor qiymatining balans qiymatiga nisbati Athira Pharma Corp|ADXN (Addex Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ALZN (alzamend.com)|CYCN - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Protagenic Therapeutics Inc. PTIX|KTTA (Pasithea) - Bozor kapitallashuvining balans qiymatiga nisbati|Cortigent, Inc. (CRGT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ATXI: Kapitallashuvning sof aktivlarga nisbati|BCLI (brainstorm-cell.com) - Bozor kapitallashuvining balans qiymatiga nisbati|CARA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CHRO|Eliem Therapeutics - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti intracellulartherapies.com ITCI|Kapitallashuvning sof aktivlarga nisbati Longboard Pharmaceuticals (LBPH)|marinuspharma.com - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati NKGen Biotech (NKGN)|NRBO - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati SAGE|Bozor qiymatining balans qiymatiga koeffitsiyenti Synaptogenix, Inc|Kapitallashuvning sof aktivlarga nisbati Trevena, Inc.|Bozor qiymatining balans qiymatiga nisbati Vigil Neuro|WENA (Anew Medical, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Cerevel Therapeutics Inc CERE